5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address Blog 5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…CertaraJune 30, 2025
How Model-informed drug development rescue projects from a risky situation Case Study How Model-informed drug development rescue projects from a risky situation Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…CertaraJune 26, 2025
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning Publication Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…Danielle PillsburyJune 19, 2025
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara Webinar From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara CertaraJune 18, 2025
Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis Webinar Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis Danielle PillsburyJune 11, 2025
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer Publication Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…CertaraJune 8, 2025
Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance On-Demand Webinar Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance SVP, PBPK Consultancy Services, Certara SVP, Quantitative Science Services, Certara Sr. Director, Clinical Pharmacology, Certara…CertaraMay 23, 2025
FDA plans to phase out animal testing requirements Press Coverage FDA plans to phase out animal testing requirements Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…CertaraApril 10, 2025
MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants On-Demand Webinar MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants Explore how model-informed drug development (MIDD) enhanced clinical lactation studies and supported global health policy…CertaraMarch 28, 2025
Video Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara CertaraMarch 27, 2025